Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharm Biopharm ; 197: 114233, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38387849

ABSTRACT

The aim of this study was to develop azithromycin (AZT)-loaded liposomes (LP) and niosomes (NS) useful for the treatment of bacterial skin infections and acne. LP based on phosphatidylcholine from egg yolk (EPC) or from soybean lecithin (SPC), and NS composed of sorbitan monopalmitate (Span 40) or sorbitan monostearate (Span 60) were prepared through the thin film hydration (TFH) and the ethanol injection (EI) methods. The formulations were subsequently characterized for their physico-chemical and functional properties. Vesicles prepared through TFH showed higher average sizes than the corresponding formulations obtained by EI. All the vesicles presented adequate encapsulation efficiency and a negative ζ potential, which assured good stability during the storage period (except for LP-SPC). Formulations prepared with TFH showed a more prolonged AZT release than those prepared through EI, due to their lower surface area and multilamellar structure, as confirmed by atomic force microscopy nanomechanical characterization. Finally, among all the formulations, NS-Span 40-TFH and LP-EPC-TFH allowed the highest drug accumulation in the skin, retained the antimicrobial activity and did not alter fibroblast metabolism and viability. Overall, they could ensure to minimize the dosing and the administration frequency, thus representing promising candidates for the treatment of bacterial skin infections and acne.


Subject(s)
Acne Vulgaris , Liposomes , Humans , Liposomes/chemistry , Excipients/metabolism , Azithromycin/pharmacology , Azithromycin/metabolism , Skin/metabolism , Acne Vulgaris/metabolism
2.
Hum Exp Toxicol ; 36(4): 319-327, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27206702

ABSTRACT

Metal-on-metal (MoM) hip prostheses are known to release chromium and cobalt (Co), which negatively affect the health status, leading to prosthesis explant. Albumin (ALB) is the main serum protein-binding divalent transition metals. Its binding capacity can be affected by gene mutations or modification of the protein N-terminal region, giving the ischaemia-modified albumin (IMA). This study evaluated ALB, at gene and protein level, as marker of individual susceptibility to Co in MoM patients, to understand whether it could be responsible for the different management of this ion. Co was measured in whole blood, serum and urine of 40 MoM patients. A mutational screening of ALB was performed to detect links between mutations and metal binding. Finally, serum concentration of total ALB and IMA were measured. Serum total ALB concentration was in the normal range for all patients. None of the subjects presented mutations in the investigated gene. Whole blood, serum and urine Co did not correlate with serum total ALB or IMA, although IMA was above the normal limit in most subjects. The individual susceptibility is very important for patients' health status. Despite the limited results of this study, we provide indications on possible future investigations on the toxicological response to Co.


Subject(s)
Albumins/genetics , Cobalt , Hip Prosthesis , Metal-on-Metal Joint Prostheses , Serum Albumin/analysis , Aged , Biomarkers/analysis , Biomarkers/metabolism , Cobalt/blood , Cobalt/urine , Female , Humans , Male , Middle Aged , Mutation , Polymorphism, Single Nucleotide
3.
Ann Hum Genet ; 68(Pt 6): 546-54, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15598213

ABSTRACT

Down Syndrome (DS) is caused by the presence of three copies of the whole human chromosome 21 (HC21) or of a HC21 restricted region; the phenotype is likely to have originated from the altered expression of genes in the HC21. We apply the cDNA microarray method to the study of gene expression in human T lymphocytes with trisomy 21 in comparison to normal cells. Two patients with DS were investigated, along with two normal subjects as a control, all being tested in independent, duplicated cell culture experiments. The most consistent finding was the overexpression of the superoxide dismutase gene (SOD1), located on 21q, and of MHC DR beta 3 (HLA-DRB3), GABA receptor A gamma 2 (GABRG2), acetyltransferase Coenzyme, A 2 (ACAT2) and ras suppressor protein 1 (RSU1) genes. When the data were clustered according to chromosome localization, the HC21 gene set showed, on average, the highest expression in DS cells in all the experiments. Moreover, separate clustering of patients and controls was obtained when analysis was restricted to HC21 gene expression values. These findings reinforce the specific gene dosage theory for the pathogenesis of the DS phenotype, and show a consistent overexpression of the SOD1 gene on 21q.


Subject(s)
Down Syndrome/genetics , Gene Expression/physiology , T-Lymphocytes/metabolism , Down Syndrome/metabolism , Flow Cytometry , Gene Expression Profiling , Humans , Oligonucleotide Array Sequence Analysis
4.
Bioinformatics ; 20(16): 2883-5, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15145799

ABSTRACT

UNLABELLED: Extracting the desired data from a database entry for later analysis is a constant need in the biological sequence analysis community; GeneRecords 1.0 is a solution for GenBank biological flat file parsing, as it implements a structured representation of each feature and feature qualifier in GenBank following import in a common database managing system usable in a personal computer (Macintosh and Windows environments). This collection of related databases enables the local management of GenBank records, allowing indexing, retrieval and analysis of both information and sequences on a personal computer. AVAILABILITY: The current release, including the FileMaker Pro runtime application (built for Windows and Macintosh environments), is freely available at http://apollo11.isto.unibo.it/software/


Subject(s)
Database Management Systems , Databases, Genetic , Documentation/methods , Information Storage and Retrieval/methods , Microcomputers , Sequence Analysis/methods , User-Computer Interface , Software
5.
Eur J Histochem ; 45(2): 151-62, 2001.
Article in English | MEDLINE | ID: mdl-11512636

ABSTRACT

Lung branching morphogenesis is a result of epithelial-mesenchymal interactions, which are in turn dependent on extracellular matrix composition and cytokine regulation. Polyamines have recently been demonstrated as able to modify chick embryo skin differentiation. In this work we have examined the effects of putrescine and spermidine during chick embryo lung morphogenesis in organotypic cultures by morphological, histochemical and biochemical examination. To verify the role of polyamines, we used specific inhibitors, such as bis-cyclohexylammonium sulphate and alfa-difluoromethylornithine, and transforming growth factor beta1, an ornithine decarboxylase and polyamine stimulator. Our data show that lung morphogenesis is significantly altered following the induced mesenchymal glycosaminoglycan changes. The increase of mesenchymal glycosaminoglycans is correlated with a stimulation of lung development in the presence of polyamines, and with its inhibition when transforming growth factor beta1 is added to the culture medium. The morphometric data show a uniform increase of both the mesenchyme and epithelial branching with spermidine and putrescine stimulus, whereas the mesenchymal substance alone is significantly increased in apical-median lung sections with transforming growth factor beta1 and transforming growth factor beta1 + spermidine lung cultures. Transforming growth factor beta1 and transforming growth factor beta1 + spermidine confirm the blocking of epithelial branching formations and fibroblast activation, and show that polyamines are unable to prevent the blocking of epithelial cells due to the inhibitory effect of transforming growth factor beta1.


Subject(s)
Lung/embryology , Mesoderm/physiology , Polyamines/metabolism , Respiratory Mucosa/physiology , Transforming Growth Factor beta/physiology , Animals , Cells, Cultured , Chick Embryo , Glycosaminoglycans/biosynthesis , Lung/metabolism , Lung/pathology , Mesoderm/metabolism , Morphogenesis , Organ Culture Techniques , Ornithine Decarboxylase/metabolism , Respiratory Mucosa/metabolism , Transforming Growth Factor beta/metabolism , Transforming Growth Factor beta1
6.
Exp Cell Res ; 266(2): 323-32, 2001 Jun 10.
Article in English | MEDLINE | ID: mdl-11399060

ABSTRACT

It is known that DNA fragmentation during apoptosis is controlled by a number of factors, a crucial step being the caspase-operated cleavage of ICAD, the DNase inhibitor. We have previously demonstrated that hydrogen peroxide-treated lymphocytes undergo apoptosis without formation of a DNA ladder; however, the use of micromolar amounts of a Zn(2+) chelator allowed DNA cleavage at internucleosomal sites. Such results were extended in the present work, thus allowing their framing into the events related to alterations in the redox state of the cell. Apoptosis in hydrogen peroxide-treated lymphocytes was found to occur with caspase-3 activation, but the enzyme activity was found to be impaired, thus affecting internucleosomal fragmentation as well as nuclear morphology. Caspase-3 activity was found to resume upon mild Zn(2+) chelation. These results provide as well an experimental model from which apoptotic events upstream and downstream of caspase-3 activity can be examined.


Subject(s)
Apoptosis , Caspases/metabolism , Zinc/physiology , Adult , Apoptosis/drug effects , Caspase 3 , Cell Nucleus/ultrastructure , Cells, Cultured , Chelating Agents/pharmacology , Enzyme Precursors/metabolism , Ethylenediamines/pharmacology , Humans , Hydrogen Peroxide/pharmacology , Intracellular Membranes/metabolism , Kinetics , Lymphocytes/cytology , Lymphocytes/metabolism , Lymphocytes/ultrastructure , Male , Middle Aged , Mitochondria/metabolism , Oxidation-Reduction , Oxidative Stress , Permeability , Phosphatidylserines/metabolism , Poly(ADP-ribose) Polymerases/metabolism
7.
Br J Pharmacol ; 133(2): 217-28, 2001 May.
Article in English | MEDLINE | ID: mdl-11350857

ABSTRACT

Transfection of the pre-monomyelocytic U937 cell line with a plasmid coding for full-length annexin 1 (ANX1, 347 amino acid) leads to cell death by promoting apoptosis. In addition, over-expression of the N-terminal and the first domain of the protein (144 amino acids, clone ANX1-S), which does not contain the Ca2+ binding sites, gives susceptibility to cell apoptosis following activation by either 5 ng ml(-1) tumour necrosis factor (TNF)-alpha or 1 - 40 microg ml-1 etoposide. This was demonstrated by using the fluorescent labelled annexin V, cell cycle and nuclear staining analyses. Transfection with an empty plasmid (clone CMV) or with a plasmid carrying the cDNA antisense for ANX1 (clone ANX1-AS) did not alter U937 cells to the degree of apoptosis promoted by either stimulant. Treatment of CMV U937 cells with TNF-alpha increased ANX1 mRNA and protein expression in a time-dependent manner, with maximal increases at 3 and 6 h, respectively. Clone ANX1-S showed higher constitutive (more than 2 fold) and activated caspase-3 activity, associated with higher phospholipase A2 (PLA2) activity (in the region of +50 - 100%), whereas expression of cytosolic PLA2 Bax and Bcl-2 were similar in all cell clones, as determined by Western blotting. In conclusion, this study demonstrates a complex regulatory role of cell apoptosis for ANX1, at least with regards to cells of the myelo-monocytic lineage.


Subject(s)
Annexin A1/genetics , Apoptosis/genetics , Apoptosis/physiology , Caspases/physiology , Monocytes/metabolism , Arachidonic Acid/metabolism , Benzimidazoles , Binding Sites/genetics , Calcium/metabolism , Caspase 3 , Cell Adhesion Molecules/metabolism , Cell Cycle/physiology , Enzyme Activation/physiology , Fluorescein-5-isothiocyanate , Fluorescent Dyes , Humans , Monocytes/enzymology , Mutagenesis, Site-Directed , Plasmids/genetics , Reverse Transcriptase Polymerase Chain Reaction , Transfection , Tumor Necrosis Factor-alpha/pharmacology , U937 Cells
8.
Life Sci ; 66(18): PL265-70, 2000 Mar 24.
Article in English | MEDLINE | ID: mdl-10809174

ABSTRACT

The potential involvement of endogenous lipocortin 1 in the process of cellular apoptosis, particularly in cells of the myelo-monocytic lineage, has been investigated. U937 cells were transfected either with an antisense or a sense DNA for lipocortin 1 and the stable clones 36.4AS clone (20-40% lower lipocortin 1 levels) and 15S (30% higher lipocortin 1 levels) were obtained. Cell apoptosis was induced by incubation with tumor necrosis factor-alpha: optimal responses were observed within a 24 h incubation period at a 5 ng/ml concentration. Apoptosis was assessed both morphologically, by annexin V binding and cell cycle analysis with propidium iodide. Whilst no consistent difference was seen between wild type cells and clone 36.4AS, a higher incidence of apoptosis (ranging from +30% to + 60%) was observed in the 15S clone. Release of arachidonic acid from loaded cells was promoted by 24 h incubation with the cytokine, and a higher degree of release was measured in the 15S clone. These data indicate that endogenous intracellular lipocortin 1 is involved in the promotion of apoptosis in cells of the myelo-monocytic derivation.


Subject(s)
Annexin A1/biosynthesis , Apoptosis/physiology , Apoptosis/drug effects , Arachidonic Acid/metabolism , Cell Cycle/physiology , Clone Cells/drug effects , Clone Cells/metabolism , Flow Cytometry , Humans , Phospholipases A/metabolism , Tumor Necrosis Factor-alpha/pharmacology , U937 Cells
SELECTION OF CITATIONS
SEARCH DETAIL
...